Consumer Staples · Cigarettes

ISPR Ispire Technology Inc. SEC Filings & Insider Trading Activity 2026

company
CIK 194845532 filings
Russell 2000

ISPR at a glance

Ispire Technology Inc. (ISPR, SEC CIK 1948455) filed its latest 10-K annual report on September 15, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 9, 2026 and Form 4 insider filings as recently as August 14, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended June 30, 2026 (FY2026), Ispire Technology Inc. (ISPR) reported revenue of $96.0 million (down 24.7% from FY2025) and a net loss of $33.2 million. Diluted EPS was -$0.58.
  • As of September 30, 2026, 11 institutional investment managers tracked by SignalX reported holding Ispire Technology Inc. (ISPR) shares worth $1.3 million in 13F-HR filings.
  • The most recent insider open-market purchase reported on Form 4 was by Wang Michael Xue on March 2, 2026 of 100 shares at $2.38 per share.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2026
$96.0M
−24.7% vs prior year
Insiders · 90 days
0 buys · 0 sells
No open-market trades
13F holders
11 funds
$1.3M · −2 vs prior quarter
Latest 8-K
Nov 9, 2026
Item 2.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Jun 30, 2026

Full analysis →

Risk Factors

  • Regulatory risk: FDA PMTA compliance and enforcement for nicotine ENDS under Family Smoking Prevention and Tobacco Control Act; costly $1M+ per PMTA application
  • Geopolitical risk: U.S. tariffs on Chinese imports at 35% and Malaysian imports at 19%, affecting Shenzhen Yi Jia product costs, a major supplier
  • Operational risk: Dependence on Shenzhen Yi Jia (95% owned by CEO) for manufacturing; risks in scaling new Malaysian facility and controlling quality
  • Competitive risk: Pressure from largest producer Smoore International Holdings Limited and technological innovation demands in vaping market
  • Financial risk: Majority stock ownership and supplier control by CEO Tuanfang Liu pose conflicts of interest impacting pricing and governance

Business Overview

  • Core business: design, R&D, commercialization, sales of vaping hardware for nicotine and cannabis under Aspire and Ispire brands globally
  • New products: proprietary Ispire ONE™ technology introduced June 2023; development started on G-Mesh porous glass coil tech marketed as “Silica Series”
  • Strategic shift: major expansion of owned manufacturing in Malaysia, commenced in Feb 2024 with 6 lines, aiming to add 70 new lines over next 12 months
  • Quantitative highlights: revenue declined 25% to $96M in 2026 from $127M in 2025; OEM/ODM share rose to 44.5% of e-cigarette revenue in 2026 from 40.2% in 2025; employee count 88 as of Sept 2026
  • Noteworthy fact: Formation and FDA engagement of IKE joint venture with 40% ownership to develop age-gating tech for e-cigarettes, including PMTA submissions and recent FDA draft guidance linking DAR tech to flavored ENDS authorization

Management Discussion & Analysis

  • Revenue $96.0M, down 24.7% YoY from $127.5M; US sales fell $17.4M, Europe down $12.7M due to regulatory challenges
  • Gross margin 12.8% vs 17.8% prior year; gross profit $12.3M vs $22.6M, margin decline due to pricing pressure, lower cannabis product mix, and $2.8M inventory write-down
  • Europe segment best performer with $61.4M revenue (63.9%), North America weakest at $15.1M (15.8%) reflecting tightening sales strategy
  • Operating expenses down 25.8% to $44.9M driven by cuts in marketing (-40.5%) and G&A (-36.2%); net loss improved to $33.2M from $39.2M, loss per share $0.58 vs $0.69
  • Operating cash flow usage reduced to $0.6M vs $7.4M; invested $3.1M mainly in joint venture and capex; $1.3M repaid on borrowings; management expects current cash and operations to fund next 12 months but additional financing may be needed if growth accelerates or conditions worsen

AI summary of the ISPR 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Management Discussion & Analysis

  • Revenue $27.5M, down 9.3% YoY from $30.4M, Europe down $5.4M while other regions rose $4.5M
  • Gross margin 16.2% vs 17.0% YoY, operating margin (22.3%) vs (8.9%), net loss $6.4M vs $3.3M
  • Europe worst region at $15.3M, down from $20.7M; Others best growth at $6.3M vs $1.8M
  • Operating cash outflow $1.6M vs $1.2M; investing outflow $1.8M, primarily $1.6M joint venture repayment
  • Near-term outlook: cash sufficient for 12 months, with regulatory uncertainty and long-aged receivables posing headwinds

Risk Factors

  • No material changes disclosed: current risks remain those in the June 30, 2026 Form 10-K
  • Smaller reporting company exemption: Item 1A risk-factor updates not required under Regulation S-K
  • Risk factors carried forward from the 10-K filed September 15, 2026

AI summary of the ISPR 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 9, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Fiscal Q2 2026 results for quarter ended September 30, 2026
  • Press release issued November 9, 2026 with financial results and operating commentary

Item EX-99.1: Item EX-99.1

  • Q1 FY2027 revenue $27.5M, down 9.3% year over year but up 3.2% sequentially, with European regulatory pressure weighing on sales
  • Gross margin recovered to 16.2% from 6.3% sequentially, driving Adjusted EBITDA to positive $136,164 from negative $2.3M
Filed Sep 23, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Investor presentation highlights $96M TTM revenue, with e-cigarettes representing 84% as of June 30, 2026
  • Q4 FY2026 revenue reached $26.7M, up 33% year over year from $20.1M

Item 7.01: Regulation FD Disclosure

  • Updated investor presentation published September 22, 2026
  • Exhibit 99.1 contains the presentation, potentially including updated strategy, operating outlook, or financial information
Filed Sep 17, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q4 revenue $26.7M, up 32.5% YoY and 43% sequentially, signaling a meaningful operational rebound
  • FY2026 revenue fell 24.7% to $96.0M, driven by U.S. cannabis hardware and European vaping declines

Item EX-99.2: Item EX-99.2

  • Q4 revenue $26.7M, up 33% YoY and 43% sequentially, signaling accelerating demand entering fiscal 2027
  • Q4 gross margin fell to 6.3% from 12.3%, pressured by inventory impairments

Item 7.01: Regulation FD Disclosure

  • Item 7.01 incorporates Item 2.02 disclosures, directing investors to the earnings-related information elsewhere in the filing
  • Market relevance depends on the financial results or announcements presented under Item 2.02

Item 2.02: Results of Operations and Financial Condition

  • FY2026 fourth-quarter and full-year results announced for period ended June 30, 2026
  • Management earnings call held September 16, 2026, covering financial and operating performance

AI summaries of ISPR 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for ISPR

Don't miss the next ISPR filing

  • Alerts as it files. A push when ISPR files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut ISPR, by share count.
  • Ask anything. An AI agent that reads every ISPR filing and answers with sources.

ISPR alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Cox BrentAAug 14, 2026-
Burch Christopher RobertAAug 14, 2026-
Fargis JohnAAug 14, 2026-
Burch Christopher RobertAMar 19, 2026-
Fargis JohnAMar 19, 2026-
Cox BrentAMar 19, 2026-
Wang Michael XueBuyMar 2, 2026$2.38
Wang Michael XueBuyMar 2, 2026$2.41

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2024FY2025FY2026
Profitability
Revenue-$127.5M$96.0M
Gross Profit-$22.6M$12.3M
Operating Income--$37.8M-$32.6M
Net Income--$39.2M-$33.2M
Gross Margin-17.8%12.8%
Op. Margin--29.7%-33.9%
Net Margin--30.8%-34.6%
Balance Sheet
Total Assets$122.6M$102.2M$64.3M
Equity$34.5M$605K-$29.2M
ROE--6489.3%113.5%
Per Share
EPS-$-0.69$-0.58
Cash Flow
Operating CF--$7.4M-$569K
CapEx-$1.1M$306K

Source: XBRL data in Ispire Technology Inc. (ISPR)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate ISPR share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
ISPR shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202611$1.3M
Q2 202613$1.4M
Q1 202616$4.4M
Q4 202516$7.1M
Q3 202515$6.5M
Q2 202515$6.5M
Q1 202512$3.0M
Q4 20248$5.0M
Position changes: Q2 2026 → Q3 2026
Top Sellers
New Positions
None this quarter.
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 106 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

ISPR filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
10-QNov 9, 2026Analysis
8-KNov 9, 2026Analysis-
8-KSep 23, 2026Analysis-
8-KSep 17, 2026Analysis-
10-KSep 15, 2026Analysis
8-KAug 17, 2026Analysis-
4Aug 14, 2026--
4Aug 14, 2026--
4Aug 14, 2026--
8-KJul 17, 2026Analysis-
8-KJun 25, 2026Analysis-
10-QMay 7, 2026Analysis
4Mar 19, 2026--
4Mar 19, 2026--
4Mar 19, 2026--
4Mar 2, 2026--
4Feb 26, 2026--
4Feb 17, 2026-
10-QFeb 6, 2026Analysis
4Nov 24, 2025-
10-QNov 6, 2025Analysis
10-KSep 15, 2025Analysis
10-QMay 9, 2025-
10-QFeb 7, 2025-
10-QNov 12, 2024-

Related Consumer Staples companies

All Consumer Staples →

ISPR SEC filings: frequently asked questions

Which institutions hold ISPR stock?

As of September 30, 2026, the largest Ispire Technology Inc. (ISPR) holders among the 13F filers tracked by SignalX were BlackRock ($441,000), Millennium Management ($307,000), Vanguard Capital Management LLC ($260,000), Goldman Sachs Group ($92,000), State Street Corp ($83,000). 13F-HR reports are filed up to 45 days after each quarter ends.

What was ISPR's revenue in fiscal year 2026?

For the fiscal year ended June 30, 2026 (FY2026), Ispire Technology Inc. (ISPR) reported revenue of $96.0 million (down 24.7% from FY2025) and a net loss of $33.2 million. Diluted EPS was -$0.58. The figures come from the XBRL data in the 10-K.

What are the main risks in ISPR's latest 10-K?

In the 10-K filed September 15, 2026, Ispire Technology Inc. (ISPR) flagged: Regulatory risk: FDA PMTA compliance and enforcement for nicotine ENDS under Family Smoking Prevention and Tobacco Control Act; costly $1M+ per PMTA application. Geopolitical risk: U.S. tariffs on Chinese imports at 35% and Malaysian imports at 19%, affecting Shenzhen Yi Jia product costs, a major supplier. (AI summary of the Risk Factors section.)

What did ISPR report in its latest 8-K?

Ispire Technology Inc. (ISPR) filed an 8-K on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Fiscal Q2 2026 results for quarter ended September 30, 2026.

What are the latest ISPR SEC filings?

Ispire Technology Inc. (ISPR) filed its latest 10-K annual report on September 15, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 9, 2026 and a Form 4 insider filing on August 14, 2026.

What is ISPR's SEC CIK number?

Ispire Technology Inc. (ISPR)'s SEC Central Index Key (CIK) is 1948455. EDGAR lists every ISPR filing under that number.

Ask anything about ISPR

The research agent reads ISPR's filings, financials, insider trades and 13F holders, then answers with sources.